...
首页> 外文期刊>The Journal of Antibiotics: An International Journal >III. Structures of New Hibarimicin-related Metabolites Produced by Blocked Mutants
【24h】

III. Structures of New Hibarimicin-related Metabolites Produced by Blocked Mutants

机译:三,封闭突变体产生的与新霉素相关的代谢物的结构

获取原文
获取原文并翻译 | 示例
           

摘要

Structures of metabolites produced by blocked mutants of Microbispora rosea subsp. hibaria TP-A0121, hibarimicin-producer, were determined by spectroscopic analysis. HMP-66 is the dimer of the west half of hibarimicin B, the aglycon of which is the genuine biosynthetic intermediate. HMP-P1 is the shunt product arising from the release of a methanol molecule from hibarimicinone. HMP-P4, the glycoside of HMP-P1, is glycosylated with two amicetoses and two digitoxoses same as hibarimicin B. HMP-M1, M2, M3 and M4 are shunt products derived from the monomeric undecaketide intermediates.
机译:微双孢菌玫瑰亚种的封闭突变体产生的代谢物结构。通过光谱分析确定了hibararia TP-A0121,hibarimicin的生产者。 HMP-66是hibarimicin B西半部分的二聚体,其糖苷配基是真正的生物合成中间体。 HMP-P1是从Hibarimicinone释放出甲醇分子而产生的分流产物。 HMP-P4是HMP-P1的糖苷,与hibarimicin B相同,被两个乙酰氨基糖和两个洋地黄糖糖基化。HMP-M1,M2,M3和M4是衍生自单体去甲蝶呤中间体的分流产物。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号